Skip to main content
Main navigation
About us
About us
Our work
Rationale
IDDO Team
Contact us
Our partners
Governance
Governance
IDDO Board
Data Access Committee
Data reuse
Data reuse
Contributing data
Accessing data
IDDO legal and regulatory documentation
IDDO data sharing registrations
Frequently Asked Questions
Research themes
Research themes
WWARN
COVID-19
Ebola
Visceral leishmaniasis
Medicine Quality
Antimicrobial Resistance
Schistosomiasis & STHs
Chagas Disease
Febrile illness
Scrub typhus
Trachoma
Other diseases
Research
Research
Malaria Tracking Resistance
Malaria Clinical Trials Toolkit
COVID-19 LSR Tool
VL Tool
Medicine Quality Monitoring Globe
Medicine Quality Scientific Literature Surveyor
Febrile Illness Surveyor
Publications
Tools & resources
News
User account menu
Log in
Register
Contact
Bandwidth
High
Low
Language switcher
English
Français
Español
Toggle navigation
About us
Overview
AMR Team
About GRAM
Work with GRAM
Data reuse
Accessing data
Contributing data
Research
Publications
Tools & resources
AMR networks
News
Search
Search
Search
News
i
BMC Medicine
News Article
03 Apr 2019
Research highlight: New guidelines for reporting microbiology data
i
The economic costs of antimicrobial resistance (AMR) are higher than the sales price of most popular antibiotics, according to a recent MORU/IDDO study. Curbing the unnecessary use of antibiotics is key to dealing with the AMR issue head on, particularly in SE Asia, which has the highest rates of AMR and a big, informal medicine dispensing sector that aggravates the AMR problem. ©2018 MORU/Wellcome.
News Article
22 Aug 2018
Study details high hidden economic costs of antibiotic consumption
i
Credit: IDDO/ Mehul Dhorda
News Article
05 Mar 2018
Study analyses AMR networks in low- and middle-income countries
Pagination
First page
« First
Previous page
‹ Previous
Page
1
Current page
2